149 related articles for article (PubMed ID: 36031497)
21. Conservative alternatives to extirpative surgery for rectal cancer.
Myerson RJ; Hunt SR
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):682-6. PubMed ID: 17765498
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study.
Rijkmans EC; van Triest B; Nout RA; Kerkhof EM; Buijsen J; Rozema T; Franssen JH; Velema LA; Laman MS; Cats A; Marijnen CAM
Radiother Oncol; 2018 Mar; 126(3):417-423. PubMed ID: 29398154
[TBL] [Abstract][Full Text] [Related]
23. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
Sun Myint A; Smith FM; Gollins S; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman M; Pritchard DM
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):565-573. PubMed ID: 29229327
[TBL] [Abstract][Full Text] [Related]
24. Prospective phase II study of brachytherapy boost as a component of neo-adjuvant chemotherapy and external beam radiation therapy in locally advanced rectal cancer.
El-Sayed ME; El-Taher ZH
J Egypt Natl Canc Inst; 2008 Mar; 20(1):10-6. PubMed ID: 19847277
[TBL] [Abstract][Full Text] [Related]
25. High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer.
Vuong T; Devic S
J Contemp Brachytherapy; 2015 Apr; 7(2):183-8. PubMed ID: 26034500
[TBL] [Abstract][Full Text] [Related]
26. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
27. Contact X-ray brachytherapy for rectal cancer: Past, present, and future.
Gérard JP; Barbet N; Dejean C; Montagne L; Bénézery K; Coquard R; Doyen J; Durand Labrunie J; Hannoun-Lévi JM
Cancer Radiother; 2021 Dec; 25(8):795-800. PubMed ID: 34052134
[TBL] [Abstract][Full Text] [Related]
28. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study.
Appelt AL; Pløen J; Harling H; Jensen FS; Jensen LH; Jørgensen JC; Lindebjerg J; Rafaelsen SR; Jakobsen A
Lancet Oncol; 2015 Aug; 16(8):919-27. PubMed ID: 26156652
[TBL] [Abstract][Full Text] [Related]
30. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
[TBL] [Abstract][Full Text] [Related]
31. A multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - Preliminary results of the CONTEM1 study.
Dhadda A; Sun Myint A; Thamphya B; Hunter I; Hershman M; Gerard JP
Radiother Oncol; 2021 Sep; 162():195-201. PubMed ID: 34329654
[TBL] [Abstract][Full Text] [Related]
32. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
Sanfilippo NJ; Crane CH; Skibber J; Feig B; Abbruzzese JL; Curley S; Vauthey JN; Ellis LM; Hoff P; Wolff RA; Brown TD; Cleary K; Wong A; Phan T; Janjan NA
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):176-83. PubMed ID: 11516868
[TBL] [Abstract][Full Text] [Related]
33. High-dose-rate brachytherapy boost for prostate cancer: Analysis of dose-volume histogram parameters for predicting late rectal toxicity.
Chicas-Sett R; Farga D; Perez-Calatayud MJ; Celada F; Roldan S; Fornes-Ferrer V; Ibanez-Rosello B; Tormo A; Benlloch JM; Perez-Calatayud J
Brachytherapy; 2017; 16(3):511-517. PubMed ID: 28366276
[TBL] [Abstract][Full Text] [Related]
34. Evolving role of neoadjuvant therapy in rectal cancer.
Schrag D
Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
[TBL] [Abstract][Full Text] [Related]
35. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.
Jakobsen A; Mortensen JP; Bisgaard C; Lindebjerg J; Hansen JW; Rafaelsen SR
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):461-5. PubMed ID: 16226396
[TBL] [Abstract][Full Text] [Related]
36. Rectal cancer: review with emphasis on MR imaging.
Beets-Tan RG; Beets GL
Radiology; 2004 Aug; 232(2):335-46. PubMed ID: 15286305
[TBL] [Abstract][Full Text] [Related]
37. Predicting residual rectal adenocarcinoma in the surgical specimen after preoperative brachytherapy with endoscopic ultrasound.
Romagnuolo J; Parent J; Vuong T; Bélanger M; Michel RP; Belliveau PJ; Trudel JL
Can J Gastroenterol; 2004 Jul; 18(7):435-40. PubMed ID: 15229745
[TBL] [Abstract][Full Text] [Related]
38. A systematic overview of radiation therapy effects in prostate cancer.
Nilsson S; Norlén BJ; Widmark A
Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
[TBL] [Abstract][Full Text] [Related]
39. Brachytherapy and local excision for sphincter preservation in T1 and T2 rectal cancer.
Grimard L; Stern H; Spaans JN
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):803-9. PubMed ID: 19250765
[TBL] [Abstract][Full Text] [Related]
40. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]